TOTAL VOLUME:
$134.1b
24H VOL:
$133,388,117
24H TRANSACTIONS:
2,388,728,490
OPEN INTEREST:
$1,436,095,462
405,232
Markets across
30,526
events
MATCHED EVENTS:
2,693
PLATFORM COVERAGE:
5
Polymarket:
39%
VS.
Kalshi:
61%
Closed: Aug 4, 6:12 PM EST
Polymarket
As of market creation, Hinge Health is estimated to release earnings on August 4, 2026. The Street consensus estimate for Hinge Health's GAAP EPS for the relevant quarter is $0.39 as of market creation. This market will resolve to "Yes" if Hinge Health reports GAAP EPS greater than $0.39 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Hinge Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, Hinge Health is estimated to release earnings on August 4, 2026. The Street consensus estimate for Hinge Health's GAAP EPS for the relevant quarter is $0.39 as of market creation. This market will resolve to "Yes" if Hinge Health reports GAAP EPS greater than $0.39 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Hinge Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Currently, this market reflects a strong tilt toward an earnings beat, contrasting with some analyst forecasts that are more evenly split. While analysts may weigh financial metrics and guidance differently, traders are incorporating real-time market signals and sentiment. The gap between the two can highlight areas where investor confidence diverges from traditional equity research, often amplifying price action ahead of the earnings release.
This market resolves around Aug 4, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. The result will depend on officially released quarterly earnings data and whether it meets or exceeds consensus analyst estimates. Traders should monitor official company announcements and reputable financial news sources for timely confirmation.
Pre-earnings analyst upgrades or downgrades, revenue guidance changes, and macro-economic indicators affecting the healthcare sector can all shift this market. Media coverage of clinical trial results, management commentary in interviews, and market reactions to peer company earnings may also influence trader sentiment. Any unexpected news flow closer to the release date typically creates volatility in pricing.